Northwestern Medicine scientists have discovered that targeting neuronal signaling controlling aberrant learning in the ...

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

Rilzabrutinib (Wayrilz; Sanofi), a BTK inhibitor, targets immune-mediated platelet destruction in immune thrombocytopenia (ITP) and has demonstrated a favorable safety profile.

Medscape Medical News talked with researcher Stacie Dusetzina about the prospects for a single-payer program to help with the ...